About
Oral immunotherapy, supplements
Areas of Focus
Categories
Biologics & BiopharmaceuticalAustralia
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
4
As Collaborator
2
Total Enrollment
299
By Phase
PHASE2: 5PHASE1/PHASE2: 1
By Status
COMPLETED: 4TERMINATED: 1WITHDRAWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05933525Lead Sponsor
Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model
PHASE2Completed
60 participants
Started: May 29, 2023 · Completed: Dec 30, 2024
NCT03065374Lead Sponsor
Treatment for Clostridium-difficile Infection With IMM529
PHASE1/PHASE2Terminated
9 participants
Started: Sep 1, 2017 · Completed: Nov 7, 2019
NCT03042767Collaborator
Anti-LPS Antibody Treatment for Pediatric NAFLD
PHASE2Completed
40 participants
Started: Feb 1, 2017 · Completed: Oct 23, 2019
NCT02316717Lead Sponsor
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
PHASE2Completed
133 participants
Started: Dec 31, 2014 · Completed: Oct 30, 2017
NCT01968382Collaborator
Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis
PHASE2Completed
57 participants
Started: Dec 31, 2014 · Completed: Dec 22, 2018
Locations (1)
Headquarters
Blackburn North, Australia
Map
Loading map...